Literature DB >> 25555213

TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization.

Mauricio T Caballero, M Elina Serra, Patricio L Acosta, Jacqui Marzec, Luz Gibbons, Maximiliano Salim, Andrea Rodriguez, Andrea Reynaldi, Alejandro Garcia, Daniela Bado, Ursula J Buchholz, Diego R Hijano, Silvina Coviello, Dawn Newcomb, Miguel Bellabarba, Fausto M Ferolla, Romina Libster, Ada Berenstein, Susana Siniawaski, Valeria Blumetti, Marcela Echavarria, Leonardo Pinto, Andrea Lawrence, M Fabiana Ossorio, Arnoldo Grosman, Cecilia G Mateu, Carola Bayle, Alejandra Dericco, Mariana Pellegrini, Ignacio Igarza, Horacio A Repetto, Luciano Alva Grimaldi, Prathyusha Gudapati, Norberto R Polack, Fernando Althabe, Min Shi, Fernando Ferrero, Eduardo Bergel, Renato T Stein, R Stokes Peebles, Mark Boothby, Steven R Kleeberger, Fernando P Polack.   

Abstract

While 30%-70% of RSV-infected infants develop bronchiolitis, 2% require hospitalization. It is not clear why disease severity differs among healthy, full-term infants; however, virus titers, inflammation, and Th2 bias are proposed explanations. While TLR4 is associated with these disease phenotypes, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is controversial. Here, we evaluated the interaction between TLR4 and environmental factors in RSV disease and defined the immune mediators associated with severe illness. Two independent populations of infants with RSV bronchiolitis revealed that the severity of RSV infection is determined by the TLR4 genotype of the individual and by environmental exposure to LPS. RSV-infected infants with severe disease exhibited a high GATA3/T-bet ratio, which manifested as a high IL-4/IFN-γ ratio in respiratory secretions. The IL-4/IFN-γ ratio present in infants with severe RSV is indicative of Th2 polarization. Murine models of RSV infection confirmed that LPS exposure, Tlr4 genotype, and Th2 polarization influence disease phenotypes. Together, the results of this study identify environmental and genetic factors that influence RSV pathogenesis and reveal that a high IL-4/IFN-γ ratio is associated with severe disease. Moreover, these molecules should be explored as potential targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25555213      PMCID: PMC4319428          DOI: 10.1172/JCI75183

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  59 in total

Review 1.  Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease.

Authors:  Eric A F Simoes
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

2.  Respiratory syncytial virus in young children.

Authors:  Caroline Breese Hall
Journal:  Lancet       Date:  2010-05-01       Impact factor: 79.321

3.  Immunomodulation with IL-4R alpha antisense oligonucleotide prevents respiratory syncytial virus-mediated pulmonary disease.

Authors:  Michael J Ripple; Dahui You; Srinivasa Honnegowda; Joseph D Giaimo; Andrew B Sewell; David M Becnel; Stephania A Cormier
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

4.  Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.

Authors:  Ruth A Karron; Peter F Wright; Robert B Belshe; Bhagvanji Thumar; Roberta Casey; Frances Newman; Fernando P Polack; Valerie B Randolph; Anne Deatly; Jill Hackell; William Gruber; Brian R Murphy; Peter L Collins
Journal:  J Infect Dis       Date:  2005-03-01       Impact factor: 5.226

5.  TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.

Authors:  Bart Ferwerda; Matthew B B McCall; Santos Alonso; Evangelos J Giamarellos-Bourboulis; Maria Mouktaroudi; Neskuts Izagirre; Din Syafruddin; Gibson Kibiki; Tudor Cristea; Anneke Hijmans; Lutz Hamann; Shoshana Israel; Gehad ElGhazali; Marita Troye-Blomberg; Oliver Kumpf; Boubacar Maiga; Amagana Dolo; Ogobara Doumbo; Cornelus C Hermsen; Anton F H Stalenhoef; Reinout van Crevel; Han G Brunner; Djin-Ye Oh; Ralf R Schumann; Concepcion de la Rúa; Robert Sauerwein; Bart-Jan Kullberg; André J A M van der Ven; Jos W M van der Meer; Mihai G Netea
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-09       Impact factor: 11.205

6.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

7.  Common human Toll-like receptor 4 polymorphisms--role in susceptibility to respiratory syncytial virus infection and functional immunological relevance.

Authors:  Stéphane C Paulus; Aaron F Hirschfeld; Rachel E Victor; John Brunstein; Eva Thomas; Stuart E Turvey
Journal:  Clin Immunol       Date:  2007-04-20       Impact factor: 3.969

Review 8.  TLR4 signalling in pulmonary stromal cells is critical for inflammation and immunity in the airways.

Authors:  Frederic Perros; Bart N Lambrecht; Hamida Hammad
Journal:  Respir Res       Date:  2011-09-24

9.  Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen.

Authors:  Stephanie C Eisenbarth; Damani A Piggott; James W Huleatt; Irene Visintin; Christina A Herrick; Kim Bottomly
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease.

Authors:  Beena Puthothu; Johannes Forster; Andrea Heinzmann; Marcus Krueger
Journal:  Dis Markers       Date:  2006       Impact factor: 3.434

View more
  60 in total

1.  Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.

Authors:  Luan D Vu; David Siefker; Tamekia L Jones; Dahui You; Ryleigh Taylor; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

Review 2.  Viral manipulation of the host immune response.

Authors:  Allison Christiaansen; Steven M Varga; Juliet V Spencer
Journal:  Curr Opin Immunol       Date:  2015-07-10       Impact factor: 7.486

3.  Pulmonary Dendritic Cell Subsets Shape the Respiratory Syncytial Virus-Specific CD8+ T Cell Immunodominance Hierarchy in Neonates.

Authors:  Allison M W Malloy; Tracy J Ruckwardt; Kaitlyn M Morabito; Annie W Lau-Kilby; Barney S Graham
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

4.  Respiratory Syncytial Virus Disease Severity Is Associated with Distinct CD8+ T-Cell Profiles.

Authors:  David T Siefker; Luan Vu; Dahui You; Andrew McBride; Ryleigh Taylor; Tamekia L Jones; John DeVincenzo; Stephania A Cormier
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

5.  An Interaction of LPS and RSV Infection in Augmenting the AHR and Airway Inflammation in Mice.

Authors:  Na Zhou; Wei Li; Luo Ren; Xiaohong Xie; Enmei Liu
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

6.  Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response.

Authors:  Sudipta Das; Mahesh Raundhal; Jie Chen; Timothy B Oriss; Rachael Huff; John V Williams; Anuradha Ray; Prabir Ray
Journal:  JCI Insight       Date:  2017-09-07

Review 7.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

8.  Long-lived regulatory T cells generated during severe bronchiolitis in infancy influence later progression to asthma.

Authors:  Jason P Lynch; Rhiannon B Werder; Bodie F Curren; Md Al Amin Sikder; Ashik Ullah; Ismail Sebina; Ridwan B Rashid; Vivian Zhang; John W Upham; Geoff R Hill; Raymond J Steptoe; Simon Phipps
Journal:  Mucosal Immunol       Date:  2020-02-17       Impact factor: 7.313

Review 9.  A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.

Authors:  Boopathy Ramakrishnan; Karthik Viswanathan; Kannan Tharakaraman; Vlado Dančík; Rahul Raman; Gregory J Babcock; Zachary Shriver; Ram Sasisekharan
Journal:  Trends Microbiol       Date:  2016-10-14       Impact factor: 17.079

10.  New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis.

Authors:  Dai Kimura; Jordy Saravia; Sridhar Jaligama; Isabella McNamara; Luan D Vu; Ryan D Sullivan; Salvatore Mancarella; Dahui You; Stephania A Cormier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.